AGP Picks
View all

European Small Business Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Small Business Network.

Press releases published on April 17, 2026

Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
CAPHRA: Making NRTs Harder to Get is Public Health Madness
Chinese Top 3 Thermal Imaging Phone Brands in 2026 Promoting Industry Standardization and Innovation
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TTEC Schedules First Quarter 2026 Earnings Release and Webcast of Investor Conference Call
True North Social Expands Instagram Marketing Services to Help Brands Navigate Algorithm Changes and Content Evolution
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
QuasarEdge Acquisition Corporation Announces Exercise of Over-Allotment Option
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026
VALUE LINE, INC. DIVIDEND HAS JUST BEEN RAISED FROM $1.30 TO $1.40 (ANNUALIZED) – ITS 12TH CONSECUTIVE INCREASE
Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Long Beach City College Wins Regional Construction Awards for Campus Upgrades
Freshpet Inc. (NASDAQ: FRPT) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.
Genesis Revival Claims Evaluated: Analyzing the Pineal Gland Support Ingredients, Side Effects Risk and User Complaints
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
OneMain Holdings, Inc. (NYSE: OMF) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
PRAME-directed Cell Therapy Using Immatics’ TCR  Induces Deep and Durable Remission in Pediatric Patient  with Advanced Metastatic Nephroblastoma
Asgard Therapeutics to present preclinical data on lead asset AT-108, a personalized, off-the-shelf gene therapy, at AACR Annual Meeting 2026

Share this page:

Sign up for:

European Small Business Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.